https://adisinsight.springer.com/drugsafety/803779123?error=cookies_not_supported&code=96ed1714-5594-44f6-90e2-a77ac203377d
Acarbose/octreotide - AdisInsight
A 50-year-old woman developed gastrointestinal side effects during treatment with acarbose while relentless constipation during treatment with octreotide
acarboseoctreotideadisinsight
https://portal.fis.tum.de/de/publications/randomized-controlled-multicentre-study-of-the-prevention-of-comp-2/
Randomized controlled multicentre study of the prevention of complications by octreotide in...
of therandomizedcontrolledstudy
https://pubmed.ncbi.nlm.nih.gov/7628270/
Consensus statement: octreotide dose titration in secretory diarrhea. Diarrhea Management Consensus...
Octreotide is an effective therapeutic option in controlling secretory diarrhea of varied etiology. However, marked patient-to-patient differences in the...
consensus statementsecretory diarrheaoctreotidedosetitration
https://scholars.lib.ntu.edu.tw/entities/publication/6f1b5579-60e9-42a2-90da-e917749bff50
Clinical Experience of the Treatment of Acromegaly with Octreotide
clinical experienceof thetreatmentacromegalyoctreotide
https://www.semanticscholar.org/topic/octreotide-prednisone/12370501
octreotide/prednisone | Semantic Scholar
octreotideprednisonesemanticscholar
https://connect.mayoclinic.org/discussion/pet-ga-68-dodatate-scan-octreotide-lar-injections/
PET Ga-68 Dodatate Scan & Octreotide LAR Injections | Mayo Clinic Connect
Injections of octreotide LAR are to stop at least 4 weeks prior to having a PET Ga-68 scan. I understand why this is the requirement....
mayo clinicpetgascan
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/55648-0632/
55648-0632 Octreotide Acetate - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
octreotide acetatendc
https://adisinsight.springer.com/drugsafety/803643959?error=cookies_not_supported&code=d58a1192-742d-405e-bedb-58b907760058
Octreotide - AdisInsight
A woman in her 60s [exact age not stated] developed acute cholecystitis during treatment with octreotide for hypercalcaemia.The woman presented at the age of 79
octreotideadisinsight
https://pubmed.ncbi.nlm.nih.gov/9652348/
[125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors
Human somatostatin (somatotropin release inhibiting factor = SRIF) receptor subtypes sst2 and sst5 were stably expressed in Chinese hamster lung fibroblast...
octreotidelabelshumansomatostatinreceptors
https://pure.psu.edu/en/publications/octreotide-sms-201-995-treatment-of-resistant-acromegaly-dosage-c/
Octreotide (SMS 201-995) treatment of resistant acromegaly: Dosage considerations and range of...
https://portal.fis.tum.de/en/publications/treatment-of-advanced-pancreatic-cancer-with-high-dose-octreotide-2/
Treatment of advanced pancreatic cancer with high-dose octreotide - Technical University of Munich
pancreatic cancer
https://adisinsight.springer.com/drugsafety/803833143?error=cookies_not_supported&code=d3a6e3dc-384f-49f7-99e7-610575f09b33
Octreotide - AdisInsight
A report described 2 patients, including a neonate and an infant boy [exact ages not stated; not all sexes stated], who exhibited lack of efficacy during
octreotideadisinsight
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/68083-0517/
68083-0517 Octreotide Acetate - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
octreotide acetatendc
https://op.europa.eu/en/web/public-procurement/procurement-details/-/procurement/b18c9da5-909e-45da-8c70-4c7867237752
Medicinal products containing octreotide, lanreotide and pasireotide - EU tenders - Publications...
medicinal productseu tenderscontainingoctreotidelanreotide
https://adisinsight.springer.com/drugsafety/803712703?error=cookies_not_supported&code=67d988ac-7b60-4f9d-9fb7-fb329390eccf
Albumin-human/octreotide - AdisInsight
A 48-year-old man exhibited lack-of-efficacy during treatment with octreotide and albumin-human for chylous ascites [not all routes and dosages stated;
albuminhumanoctreotideadisinsight
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/55390-0160/
55390-0160 Octreotide Acetate - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
octreotide acetatendc
https://pubmed.ncbi.nlm.nih.gov/34012671/
Octreotide long-acting release (LAR) in combination with other therapies for treatment of...
The review summarizes the effectiveness and available safety data on octreotide LAR in combination with other therapies in patients with NEN and may provide...
https://research-portal.uu.nl/en/publications/the-effect-of-abt-229-and-octreotide-on-interdigestive-small-bowe/
The effect of ABT-229 and octreotide on interdigestive small bowel motility, bacterial overgrowth...
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/68462-0896/
68462-0896 Octreotide Acetate - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
octreotide acetatendc